
Alcon ALC
€ 57.52
-2.14%
Geschäftsbericht 2025
hinzugefügt 18.04.2026
Land |
|
IPO-Jahr |
2019 |
Branche |
Medizinische Instrumente |
Börse |
NYSE |
Anteile |
- |
Marktkapitalisierung |
$ 40.4 B |
EBITDA (LTM) |
$ -252 M |
P/E (LTM) |
-56.4 |
P/S (LTM) |
5.73 |
EPS (LTM) |
-1.32 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 67.63 | -1.45 % | $ 13.5 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 122.92 | -2.78 % | $ 7.03 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 415.18 | -2.68 % | $ 148 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 141.38 | -0.44 % | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 113.73 | -0.09 % | $ 3.64 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.98 | -0.5 % | $ 184 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 93.03 | -3.69 % | $ 2.11 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.8 | -1.37 % | $ 82.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 1.37 % | $ 32 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 66.99 | -0.78 % | $ 3.96 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 10.15 | 6.62 % | $ 86.1 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.21 | -1.57 % | $ 4.07 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 79.22 | 0.61 % | $ 3.74 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 207.33 | -2.61 % | $ 20.4 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 29.7 | -0.57 % | $ 1.47 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.91 | -1.11 % | $ 184 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 134.34 | -1.04 % | $ 5.99 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.75 | 1.0 % | $ 223 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 333.24 | -0.5 % | $ 24.1 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 24.96 | -3.14 % | $ 1.68 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.2 | -2.63 % | $ 2.03 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 1.4 % | $ 21 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 62.8 | -3.38 % | $ 206 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 26.98 | -2.07 % | $ 1.29 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.84 | -0.54 % | $ 167 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.36 | 1.62 % | $ 10.4 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 194.55 | -1.21 % | $ 28.4 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.22 | -0.29 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.18 | 2.32 % | $ 274 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.38 | 0.32 % | $ 506 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 149.23 | -1.85 % | $ 42.9 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.24 | -0.31 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.09 | -3.66 % | $ 301 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 131.82 | 1.3 % | $ 7.41 M | Nasdaq Global Select Market,SPB |